Generics

FTC clears proposed combination of Mylan, Upjohn
The combination of Mylan and Pfizer's Upjohn business is expected to close on Nov. 16, at which time the combined company will be renamed Viatris.
FDA gives tentative nod to Zydus Cadila for generic Tradjenta
Zydus Cadila’s linagliptin tablets will be available in a dosage strength of 5 mg, pending the Food and Drug Administration's final approval.

Alembic obtains FDA nod for 2 generics

Tavaborole topical solution had a market value of roughly $82 million and fenofibrate capsules had a market value of $17 million, for the 12 months ended June 2020.
FDA gives Zydus Cadila tentative OK for generic Xeljanz

Zydus Cadila's generic Xeljanz XR tablets provide a once-daily treatment for adult patients with moderately to severely active ulcerative colitis.
Aurobindo sells Natrol to New Mountain Capital

Proceeds from Aurobindo's divestiture of Natrol will be used to reduce debt and develop other new strategic initiatives, according to the company.
Ascend Labs’ VanWinkle named Cardinal Health’s generic trade rep of the year

Schuyler VanWinkle has been recognized by Cardinal Health as Generic Trade Representative of the Year for the second time in three years.
Zydus Cadila receives FDA blessing for 2 generics

The FDA has granted approval for Zydus Cadila's generic Proventil, and generic Vesicare.
Dr. Reddy’s relaunches OTC generic famotidine tablets

The company is re-launching its famotidine tablets in 10- and 20-mg tablets, store-brand equivalents of original strength and maximum strength Pepcid AC.
FDA clears Glenmark’s generic Rapamune tablets

Rapamune and its generics had annual sales of $119.7 million for the year ended August 2020, according to IQVIA data.
Alembic receives FDA nod for generic Symmetrel

Amantadine hydrochloride tablets have a market value of roughly $13 million for the 12 months ended June 2020, according to IQVIA.

FTC clears proposed combination of Mylan, Upjohn

FDA gives tentative nod to Zydus Cadila for generic Tradjenta

Alembic obtains FDA nod for 2 generics

FDA gives Zydus Cadila tentative OK for generic Xeljanz

Aurobindo sells Natrol to New Mountain Capital

Ascend Labs’ VanWinkle named Cardinal Health’s generic trade rep of the year

Zydus Cadila receives FDA blessing for 2 generics

Dr. Reddy’s relaunches OTC generic famotidine tablets

FDA clears Glenmark’s generic Rapamune tablets

Alembic receives FDA nod for generic Symmetrel